KOSDAQSemiconductors217190

Genesem

₩5,420▲ 2.65%2026-11-18 close
Market Cap
₩71.3B
Turnover
₩600M
Volume
110K
Shares out.
13.2M
PER
71.0×
PBR
1.7×
EPS
₩90
Dividend Yield
0.78%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩50 per share · Prices as of the 2026-11-18 close

01

Report overview

KRW 85.4 billion backlog after a return to profit

Genesem returned to operating profit in the third quarter of 2026, with operating profit of KRW 2.57 billion against a prior-year operating loss, and its order backlog at the end of September 2026 of about KRW 85.4 billion is roughly 1.5 times 2025 annual sales. Converting that backlog into sales and margin recovery is the next checkpoint.

  1. 1

    Third-quarter 2026 sales rose 59.5% year on year to KRW 25.2 billion, and operating profit of KRW 2.57 billion replaced the prior-year operating loss of KRW 372 million.

  2. 2

    Operating margin fell from 14.3% in 2022 to 1.8% in 2025, and the 2025 operating profit of KRW 1.03 billion was the smallest in the 2022–2025 period.

  3. 3

    Sales have risen for two consecutive quarters since the first-quarter 2026 low, which the company attributes to the sequential delivery of orders received in the first half of 2026.

  4. 4

    Operating cash flow turned to -KRW 2.13 billion in 2025 from KRW 10.1 billion in 2024.

  5. 5

    The company has set a target of raising 2026 annual sales by more than 40% year on year, and whether it is met will be confirmed through the 2026 annual report.

02

Business structure

Genesem develops, manufactures and sells back-end automation equipment for semiconductor packaging, and its product mix is 100% back-end semiconductor equipment according to wisereport.

Core equipment lines include EMI shield process equipment, saw singulation (package cutting) equipment, flip-chip automation equipment, laser marking and cutting equipment and test handlers. In 2022 on a consolidated basis, EMI shield accounted for 32.9% of sales and saw singulation for 29.4%.

For the cumulative period through the third quarter of 2023, saw singulation was 28.8%, EMI shield 20.9%, flip-chip automation 17.5%, other equipment 16.9% and parts 10.1%, according to a Korea IR Consortium research report from December 2023.

By region, domestic sales were 49.3% in 2022, Asian customers 45.5% and Mexico 4.6%; in 2024, domestic sales were 42.71% and exports 57.29%. Key customers are domestic and overseas IDMs, OSATs and PCB board makers.

A supply contract with SK hynix for HBM-related back-end equipment, worth about KRW 6.0 billion, runs from April 15 to September 15, 2026. The micro saw, the core cutting component of saw singulation equipment, is dominated globally by Japan's Disco, which constrains component sourcing.

R&D spending was 8.28% of 2024 sales (about KRW 5.69 billion), and the company said in its November 2026 disclosure that it has commercialized AI-based vision inspection in pick-and-place equipment.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩15.8B-₩400M−2.4%
2025Q4₩14B₩54,176,0030.4%
2026Q1₩6.7B-₩2.5B−36.7%
2026Q2₩23.3B₩4.2B17.9%
2026Q3₩25.2B₩2.6B10.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩59.6B₩8.5B₩12.2B14.3%30.4%97.0%
2023₩56.5B₩3.6B₩3.7B6.3%8.7%83.3%
2024₩68.7B₩6.5B₩6.1B9.5%12.2%73.2%
2025₩56.8B₩1B₩900M1.8%——

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-12

04

Earnings analysis

Annual sales went from KRW 59.6 billion in 2022 to KRW 56.5 billion in 2023 (down 5.3% year on year), then rose to KRW 68.7 billion in 2024 (up 21.8%), the largest year in 2022–2025, before falling to KRW 56.8 billion in 2025 (down 17.4%).

Operating profit was largest in 2022 at KRW 8.52 billion, fell to KRW 3.56 billion in 2023 (down 58.2%), rose to KRW 6.54 billion in 2024 (up 83.7%) and was smallest in 2025 at KRW 1.03 billion (down 84.3%).

Operating margin moved from 14.3% to 6.3%, 9.5% and 1.8% over the same years, so profitability peaked in 2022 even though sales peaked in 2024.

Profit attributable to controlling shareholders followed a similar path: KRW 12.2 billion in 2022, KRW 3.73 billion in 2023, KRW 6.08 billion in 2024 and KRW 935 million in 2025. Net income including non-controlling interests was KRW 947 million in 2025.

A December 2023 analysis attributed the 2023 decline to customers cutting production and falling utilization at global OSATs, which reduced back-end equipment orders.

On a quarterly basis, Genesem swung from an operating loss of KRW 372 million in the third quarter of 2025 to operating profit of KRW 54.18 million in the fourth quarter, then to an operating loss of KRW 2.47 billion in the first quarter of 2026, which was the low point.

Operating profit then recovered to KRW 4.17 billion in the second quarter and KRW 2.57 billion in the third quarter of 2026, although third-quarter operating profit fell 38.5% from the prior quarter.

The company said rising raw material and labor costs and higher costs from expanding production capacity partly weighed on profitability. Profit attributable to controlling shareholders over the last four quarters totals KRW 1.19 billion, which remains small relative to the sales recovery.

05

Industry analysis

The demand center for back-end equipment is HBM (high-bandwidth memory) and advanced packaging.

In its third-quarter 2026 results announced on November 12, 2026, the company said it expects demand for automation equipment such as wafer handling and sorters to grow with higher HBM stacking and wider advanced packaging adoption.

It also expects opportunities in package cutting equipment, loaders and unloaders and test handlers tied to memory capex.

Coverage of the SEMICON Korea 2026 preview said the company showed HBM back-end equipment lines, 2.5D packaging equipment and hybrid bonding-related equipment, and that its 2.5D packaging loading equipment is already commercialized with sales results.

A December 2023 Korea IR Consortium analysis said the company ranked first in domestic sales of EMI shield process equipment in 2022. The same analysis said Genesem posted solid results and added new customers in the third quarter of 2023, even as several domestic back-end equipment makers reported earnings shocks.

On the other hand, the micro saw, the core component of saw singulation equipment, is dominated globally by Japan's Disco.

The 2023 analysis also noted that customers' production cuts and lower OSAT utilization had reduced back-end equipment orders, and it warned that HBM-centered and limited capex could cap broader capex expansion.

06

Outlook

The company set a target of raising 2026 annual sales by more than 40% year on year in its November 2026 announcement. Earlier coverage of the SEMICON Korea 2026 preview cited a target of more than KRW 90 billion for 2026 annual sales, which would be an increase of more than 60% year on year.

The two targets differ in timing and basis, and the more recent announcement is the 40%-plus target. The order backlog at the end of September 2026 was about KRW 85.4 billion, and the company said these orders are being delivered sequentially and reflected in sales.

In an August 2026 disclosure, the company said recognition of second-half backlog in sales would accelerate. The SK hynix supply contract ended its delivery period on September 15, 2026, so the next checkpoint is whether a new large supply contract is disclosed.

The company has begun applying AI-based vision inspection to mass-production equipment, and whether this supports margin improvement is an open question.

The company also said it will strengthen the technical competitiveness of its automation equipment and existing core back-end equipment in response to HBM and advanced packaging expansion.

Key checkpoints are whether fourth-quarter sales rise as the backlog converts and whether operating margin holds near third-quarter levels.

07

Valuation

PER
71.0×
PBR
1.7×
ROE
2.4%
EPS
₩90
BPS
₩3,839
Dividend per share
₩50

Genesem's share price sits at a high level relative to its earnings base. The high price-to-earnings multiple reflects the small KRW 1.19 billion total of profit attributable to controlling shareholders over the last four quarters, and the multiple moves lower as quarterly profit grows.

The price-to-book ratio is above 1x, which means the stock trades at a premium to book value. The debt ratio fell from 97.0% in 2022 to 73.2% in 2024, so the balance sheet is moving in a stronger direction.

The dividend yield is small relative to the share price, so earnings recovery rather than shareholder payouts is central to the valuation discussion. Profitability returned in the second and third quarters of 2026 after a first-quarter 2026 loss, which reads as a recovery in the earnings base.

How the valuation is interpreted therefore depends on how much of the order backlog converts into sales and operating profit.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-12

08

Bull factors

Backlog supports sales

The company reported an order backlog of about KRW 85.4 billion at the end of September 2026, roughly 1.5 times 2025 annual sales. Sequential delivery of these orders lifted sales to KRW 23.3 billion in the second quarter and KRW 25.2 billion in the third quarter of 2026. The company has set a target of more than 40% annual sales growth for 2026.

Quarterly return to profit

Annual operating margin was 1.8% in 2025, but quarterly operating profit turned positive from the fourth quarter of 2025. Operating profit was KRW 4.17 billion in the second quarter and KRW 2.57 billion in the third quarter of 2026, both positive. The company reported a third-quarter operating margin of 10.2%.

HBM and advanced packaging equipment

The company expects demand for wafer handling and sorter automation equipment to grow with HBM stacking and advanced packaging expansion. Its 2.5D packaging loading equipment is already commercialized with sales. The company signed an HBM-related back-end equipment supply contract with SK hynix in April 2026.

09

Bear factors

Thin annual earnings base

Operating profit in 2025 was KRW 1.03 billion, the smallest in the 2022–2025 period, and profit attributable to controlling shareholders was KRW 935 million. Operating cash flow in 2025 was -KRW 2.13 billion. Profit attributable to controlling shareholders over the last four quarters totals only KRW 1.19 billion.

Quarterly volatility

In the first quarter of 2026 the company posted an operating loss of KRW 2.47 billion and a loss attributable to controlling shareholders of KRW 1.68 billion. Third-quarter 2026 operating profit fell 38.5% from the prior quarter.

The company said higher raw material and labor costs and capacity expansion costs partly weighed on profitability.

Cycle sensitivity and component dependence

Annual sales have moved between KRW 56.5 billion and KRW 68.7 billion since 2022, and in 2023 customer production cuts and lower OSAT utilization reduced equipment orders. The micro saw, the core component of saw singulation equipment, is dominated by Japan's Disco. This structure can widen earnings swings when the industry slows.

10

Risk factors

Industry and capex cycle

A December 2023 analysis raised concern that back-end capex centered on HBM could limit recovery in general-purpose demand. Equipment orders fall when customers cut production, which makes sales volatile. Annual sales declined in both 2023 and 2025, which illustrates this risk.

Pace of backlog conversion

The timing of converting the KRW 85.4 billion backlog into sales depends on delivery and inspection schedules. The SK hynix contract pays 90% after delivery and 10% after inspection, so inspection delays could affect cash flow. Operating cash flow of -KRW 2.13 billion in 2025 is also relevant to this risk.

Cost increases

The company said rising raw material and labor costs, along with expansion costs, partly weighed on third-quarter 2026 profitability. The 2025 operating margin of 1.8% leaves little cushion. If costs rise faster than sales recover, margin improvement could be limited.

11

What to watch next

  1. December 31, 2026

    The close of fiscal 2026, when the question is how much of the KRW 85.4 billion backlog at the end of September converts into fourth-quarter sales, which sets the starting point for annual results.

  2. March 31, 2027 (annual report filing deadline)

    The 2026 annual report is due on DART, allowing confirmation of reported annual sales against the 40%-plus growth target and of the operating margin.

  3. May 15, 2027 (first-quarter report filing deadline)

    The first-quarter 2027 results will show whether quarterly profitability continues after the KRW 2.47 billion operating loss in the first quarter of 2026, and whether profit declines from quarter to quarter recur.

  4. Ongoing disclosures (dates not set)

    New single-sales or supply contract disclosures will show whether the backlog is expanding and how much HBM-related equipment is included. With the SK hynix contract period ending on September 15, 2026, follow-on large contracts are the key item to watch.

12

Overall view

Genesem's annual operating profit fell to KRW 1.03 billion in 2025, and it has since posted quarterly profits in the second and third quarters of 2026, which points to an earnings recovery.

The order backlog of about KRW 85.4 billion at the end of September 2026 and the 40%-plus annual sales growth target are presented as the basis for that recovery.

However, third-quarter operating profit fell from the prior quarter, and profit attributable to controlling shareholders over the last four quarters totals only KRW 1.19 billion. Negative operating cash flow in 2025 means how quickly backlog converts into cash needs to be confirmed.

Bullish factors are HBM and advanced packaging equipment demand, commercialization of 2.5D equipment and the size of the backlog, while bearish factors are HBM-centered capex, cost increases and quarterly earnings volatility.

Valuation sits at a high level relative to the earnings base, so whether sales conversion and margin recovery are confirmed in disclosures is the central issue. The next checkpoints are the conversion of orders by fiscal year-end 2026, the 2026 annual report and the first-quarter 2027 report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. butler.works
  2. ssl.pstatic.net
  3. newspim.com
  4. thelec.kr
  5. topstarnews.net
  6. catch.co.kr
  7. comp.wisereport.co.kr
  8. news.nate.com
  9. digitaltoday.co.kr
  10. widedaily.com
  11. thelec.kr
  12. newstong.co.kr
  13. m.thinkpool.com
  14. goinsider.kr
  15. comp.fnguide.com
  16. specialtimes.co.kr

Report written 2026-11-13 · Data as of 2026-11-12

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis